MCID: MLG074
MIFTS: 40

Malignant Mesenchymoma

Categories: Cancer diseases, Nephrological diseases, Rare diseases

Aliases & Classifications for Malignant Mesenchymoma

MalaCards integrated aliases for Malignant Mesenchymoma:

Name: Malignant Mesenchymoma 12 52 15
Malignant Mesenchymal Tumor 52 43 71
Rat Malignant Renal Mesenchymal Tumor 71
Mesenchymoma, Malignant 12
Sarcoma 71

Classifications:



External Ids:

Disease Ontology 12 DOID:5758
MeSH 43 C535700
NCIt 49 C4268
SNOMED-CT 67 89623007
UMLS 71 C0334492 C1261473 C1882762

Summaries for Malignant Mesenchymoma

MalaCards based summary : Malignant Mesenchymoma, also known as malignant mesenchymal tumor, is related to gallbladder sarcoma and mesenchymal chondrosarcoma. An important gene associated with Malignant Mesenchymoma is MB (Myoglobin), and among its related pathways/superpathways is Mesenchymal Stem Cells and Lineage-specific Markers. The drugs Lopinavir and Lamivudine have been mentioned in the context of this disorder. Affiliated tissues include bone, lung and t cells, and related phenotype is muscle.

Related Diseases for Malignant Mesenchymoma

Diseases in the Malignant Mesenchymoma family:

Adult Malignant Mesenchymoma

Diseases related to Malignant Mesenchymoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 260)
# Related Disease Score Top Affiliating Genes
1 gallbladder sarcoma 32.3 MYOG MYOD1 DES
2 mesenchymal chondrosarcoma 30.4 MYOG MYOD1 DES
3 myxosarcoma 30.3 MB CALD1
4 skin sarcoma 30.1 CD34 CALD1
5 fibrous histiocytoma 30.0 SERPINA3 MYOG DES CD34
6 liposarcoma 30.0 MYOG MDM2 MB DES CD34
7 adenosarcoma 30.0 SERPINA3 MB DES
8 fibroma 29.9 SERPINA3 DES CD34
9 leiomyosarcoma 29.9 SERPINA3 MYOG MDM2 MB DES
10 pleomorphic liposarcoma 29.9 SERPINA3 MDM2 DES
11 neurilemmoma 29.8 SERPINA3 DES CD34
12 chondrosarcoma, extraskeletal myxoid 29.7 SSX2 MYOG CD34
13 spindle cell rhabdomyosarcoma 29.6 MYOG MYOD1 MB DES
14 alveolar soft part sarcoma 29.6 MYOG MYOD1 MB DES
15 endometrial stromal sarcoma 29.6 MB DES CALD1
16 pleomorphic lipoma 29.5 SERPINA3 MDM2 CD34
17 liposarcoma of bone 29.5 MYOG MDM2 CD34
18 rhabdomyosarcoma 29.5 SSX2 MYOG MYOD1 MDM2 MB DES
19 angiosarcoma 29.4 MYOG MDM2 CD34
20 gliosarcoma 29.4 SERPINA3 MDM2 CD34
21 mesenchymal cell neoplasm 29.3 SSX2 SERPINA3 MYOG CD34 CALD1
22 uterine carcinosarcoma 29.3 MDM2 MB DES
23 extraosseous osteosarcoma 29.2 MYOG MDM2 CD34 CALD1
24 embryonal sarcoma 29.0 SERPINA3 MYOG MYOD1 MDM2 DES
25 spindle cell sarcoma 28.9 SSX2 SERPINA3 MYOG MDM2 DES CD34
26 sarcoma 28.9 SSX2 SERPINA3 MYOG MYOD1 MDM2 DES
27 malignant fibrous histiocytoma 28.9 SERPINA3 MYOG MYOD1 MDM2 MB DES
28 ewing sarcoma 28.9 MYOG MDM2 DES CD34
29 lipomatosis, multiple 28.6 SERPINA3 MDM2 DES CD34 CALD1
30 retroperitoneal sarcoma 28.5 SSX2 MYOG MDM2 CD34 CALD1
31 sarcoma, synovial 28.4 SSX2 SERPINA3 MYOG MDM2 DES CD34
32 well-differentiated liposarcoma 28.4 SSX2 SERPINA3 MYOG MDM2 CD34 CALD1
33 hemangiopericytoma, malignant 27.6 SSX2 SERPINA3 MYOG MDM2 DES CD34
34 myxofibrosarcoma 27.6 SSX2 SERPINA3 MYOG MDM2 DES CD34
35 dedifferentiated liposarcoma 27.6 SSX2 SERPINA3 MYOG MDM2 MB DES
36 muscle cancer 27.4 SSX2 SERPINA3 MYOG MYOD1 MDM2 MB
37 childhood malignant mesenchymoma 12.4
38 adult malignant mesenchymoma 12.4
39 sarcoma of cervix uteri 11.5
40 osteogenic sarcoma 10.7
41 chondrosarcoma 10.6
42 giant cell myocarditis 10.4 MB DES
43 fibrosarcoma 10.4
44 bladder sarcoma 10.4 SERPINA3 MYOG
45 orbit rhabdomyosarcoma 10.4 MYOG MB
46 congenital epulis 10.4 SERPINA3 DES
47 epulis 10.4 SERPINA3 DES
48 inflammatory leiomyosarcoma 10.4 MYOG DES
49 orbit embryonal rhabdomyosarcoma 10.4 MYOG MB
50 syringocystadenoma papilliferum 10.4 SERPINA3 DES

Graphical network of the top 20 diseases related to Malignant Mesenchymoma:



Diseases related to Malignant Mesenchymoma

Symptoms & Phenotypes for Malignant Mesenchymoma

MGI Mouse Phenotypes related to Malignant Mesenchymoma:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 9.1 DES MB MDM2 MYOD1 MYOG SMTN

Drugs & Therapeutics for Malignant Mesenchymoma

Drugs for Malignant Mesenchymoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 595)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lopinavir Approved Phase 4 192725-17-0 92727
2
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
3
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
4
Aprepitant Approved, Investigational Phase 4 170729-80-3 6918365 151165
5
Tranexamic Acid Approved Phase 4 1197-18-8 5526
6
Heparin Approved, Investigational Phase 4 9005-49-6 46507594 772
7
Tinzaparin Approved Phase 4 9041-08-1, 9005-49-6 25244225
8
Dalteparin Approved Phase 4 9005-49-6
9
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
10
Enoxaparin Approved Phase 4 9005-49-6 772
11 Cytochrome P-450 CYP3A Inhibitors Phase 4
12 Hemostatics Phase 4
13 Antifibrinolytic Agents Phase 4
14 Coagulants Phase 4
15 Anticoagulants Phase 4
16 Fibrinolytic Agents Phase 4
17 Heparin, Low-Molecular-Weight Phase 4
18 calcium heparin Phase 4
19 Platelet Aggregation Inhibitors Phase 4
20 Antipyretics Phase 4
21
Meloxicam Approved, Vet_approved Phase 3 71125-38-7 54677470 5281106
22
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
23
Irinotecan Approved, Investigational Phase 3 97682-44-5, 100286-90-6 60838
24
Nicotine Approved Phase 3 54-11-5 942 89594
25
Darbepoetin alfa Approved, Investigational Phase 3 11096-26-7, 209810-58-2
26
Abacavir Approved, Investigational Phase 2, Phase 3 136470-78-5 441300 65140
27
Levoleucovorin Approved, Investigational Phase 3 68538-85-2
28
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
29
Sulfamethoxazole Approved Phase 3 723-46-6 5329
30
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
31
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
32
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
33
Varenicline Approved, Investigational Phase 3 249296-44-4 5310966
34
Epirubicin Approved Phase 3 56420-45-2 41867
35
Palbociclib Approved, Investigational Phase 3 571190-30-2 5005498 11431660 5330286
36
Olaparib Approved Phase 3 763113-22-0 23725625
37
Ceritinib Approved Phase 3 1032900-25-6
38
Denosumab Approved Phase 3 615258-40-7
39
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
40
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
41
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
42
Mechlorethamine Approved, Investigational Phase 3 51-75-2 4033
43
Mitoxantrone Approved, Investigational Phase 3 65271-80-9 4212
44
Idarubicin Approved Phase 3 58957-92-9 42890
45
Daunorubicin Approved Phase 3 20830-81-3 30323
46
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
47
Bortezomib Approved, Investigational Phase 3 179324-69-7 387447 93860
48
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
49
Cytarabine Approved, Experimental, Investigational Phase 3 147-94-4, 65-46-3 6253
50
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563

Interventional clinical trials:

(show top 50) (show all 1790)
# Name Status NCT ID Phase Drugs
1 EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children Unknown status NCT00339118 Phase 4 doxorubicin, cytoxan
2 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
3 A Randomized Comparison of Protease Inhibitor-based Versus Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy for Initial Treatment of Individuals With AIDS-related Kaposi's Sarcoma in Sub-Saharan Africa Completed NCT00444379 Phase 4 Lopinavir/ritonavir plus Emtricitabine/Tenofovir versus Efavirenz plus Emtricitabine/Tenofovir
4 A Prospective Randomized Trial Comparing the Response of HIV Kaposi's Sarcoma (KS) to HAART Versus the Combination of HAART and Chemotherapy (CXT) Completed NCT00380770 Phase 4 Generic HAART Triomune : d4T, 3TC, NVP;Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV
5 Prospective, Randomized Evaluation of Hyperbaric Oxygen Therapy on Wound Healing Following Management of Soft Tissue Sarcoma With Neo-Adjuvant Radiation and Surgical Resection Recruiting NCT03144206 Phase 4 Hyperbaric oxygen
6 Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma Recruiting NCT03514381 Phase 4 Patients starting a treatment with Doxorubicin and Ifosfamide
7 Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule Recruiting NCT04223583 Phase 4 Anlotinib Hydrochloride
8 Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib — a Randomized, Controlled Trial Recruiting NCT03735758 Phase 4 pazopanib or guideline conform chemotherapy
9 Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma: a Single Arm Prospective Study Recruiting NCT04056962 Phase 4 Tacrolimus ointment
10 An Open Label, Multicenter, Non-Comparative, Phase IV Study of Panitumumab to Characterize Its Safety, Tolerability and Activity in Indian Subjects With Previously Treated Wild-Type RAS (KRAS and NRAS), Metastatic Colorectal Cancer Recruiting NCT02301962 Phase 4 Panitumumab
11 Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction: A Randomized Controlled Trial Recruiting NCT04347122 Phase 4 Tranexamic Acid (TXA)
12 Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma:A Prospective, Randomized Open Trial Recruiting NCT04077515 Phase 4 Sirolimus(0.8mg/m2);Sirolimus(0.7mg/m2)
13 Low Molecular Weight Heparin Versus Aspirin for Venous Thromboembolism Prophylaxis in Orthopaedic Oncology Enrolling by invitation NCT03244020 Phase 4 Aspirin 325mg;Enoxaparin 40Mg/0.4mL Prefilled Syringe
14 Registry of Retroperitoneal, Abdominal, Pelvic and Truncal Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® to Evaluate the Safety and Feasibility Over 5 Years Not yet recruiting NCT04033081 Phase 4
15 A Phase III Randomized Study of Preoperative Radiotherapy Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcoma (RPS) Unknown status NCT01344018 Phase 3
16 Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS) Unknown status NCT00354835 Phase 3 Irinotecan Hydrochloride;Cyclophosphamide;Vincristine Sulfate
17 A Protocol For Nonmetastatic Rhabdomyosarcoma [RMS-2005] Unknown status NCT00379457 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;topotecan hydrochloride;vincristine sulfate;vinorelbine tartrate
18 A Registered Randomized, Double-Blind, Placebo-Controlled (2:1), Multi-Centered Clinical Trial of Anlotinib as a Treatment for Soft Tissue Sarcoma Unknown status NCT02449343 Phase 2, Phase 3 Anlotinib;Placebo
19 Phase III Study About the Effects of the Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas Unknown status NCT00162721 Phase 3 doxorubicin, ifosfamide, cisplatin
20 Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Adriamycin, Bleomycin, and Vincristine (ABV) in the Treatment of Severe AIDS-Related Kaposi's Sarcoma Unknown status NCT00002318 Phase 3 Doxorubicin hydrochloride (liposomal);Bleomycin sulfate;Vincristine sulfate;Doxorubicin hydrochloride
21 Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
22 MULTICENTER RANDOMIZED, OPEN-LABEL PHASE II/III STUDY, TO COMPARE EFFICACY OF NBTXR3 IMPLANTED AS INTRATUMOR INJECTION AND ACTIVATED BY RADIOTHERAPY, VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMA (EXTREMITY AND TRUNK WALL) Unknown status NCT02379845 Phase 2, Phase 3
23 EUROPEAN INTERGROUP COOPERATIVE EWING'S SARCOMA STUDY [EICESS 92] Unknown status NCT00002516 Phase 3 cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;mesna;vincristine sulfate
24 Intensified Methotrexate, Vinblastine, Doxorubicin and Cisplatin +/-Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma in Patients Without Harvey Nor Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations. Phase II Study Unknown status NCT02818725 Phase 3 Chemotherapy;panitumumab
25 Phase III Study of The Role of Barrier Resection in Local Control in Treatment of Extremity Soft Tissue Sarcomas Unknown status NCT02120768 Phase 3
26 European Ewing Tumour Working Initiative of National Groups Ewing Tumour Studies 1999 (EURO-E.W.I.N.G.99) Unknown status NCT00020566 Phase 3 busulfan;doxorubicin hydrochloride;etoposide;ifosfamide;melphalan;vincristine sulfate
27 Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age Unknown status NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
28 Randomized Double-Blind Controlled Phase III Trial of Hyperbaric Oxygen Therapy in Patients Suffering Long-Term Adverse Effects of Radiotherapy for Pelvic Cancer (HOT II) Unknown status NCT01087268 Phase 3
29 A Double-Blind Randomized Placebo Controlled Trial for Prevention of Tuberculosis-Immune Reconstitution Inflammatory Syndrome With Non-Steroid Anti-Inflammatory Drugs (NSAIDs) in HIV-Infected Adults Unknown status NCT02060006 Phase 3 Meloxicam 7.5mg daily for 8 weeks
30 Prospective and Randomized Study of Fixed Versus Flexible Prophylactic Administration of Granulocyte Colony-Stimulating Factor (G-CSF) in Children With Cancer Unknown status NCT01987596 Phase 3
31 Comparing the Effectiveness of Combined Hyperthermia and External Beam Radiation (EBRT) Versus EBRT Alone in Treating Patients With Painful Bone Metastases Unknown status NCT01842048 Phase 3
32 Randomised Trial of Post-Operative Radiotherapy Given to Adult Patients With Extremity Soft Tissue Sarcoma [VORTEX] Completed NCT00423618 Phase 3
33 METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP) Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
34 Actinomycin D and Vincristine With or Without Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Rhabdomyosarcoma or Undifferentiated Sarcoma: IRS-V Protocol Completed NCT00002995 Phase 3 cyclophosphamide;vincristine sulfate
35 RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
36 Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma Completed NCT00354744 Phase 3 cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;irinotecan hydrochloride;vincristine sulfate
37 Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma Completed NCT00003958 Phase 3 vincristine sulfate;cyclophosphamide;topotecan hydrochloride
38 MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
39 A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy Completed NCT00753688 Phase 3 PAZOPANIB;Placebo
40 A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. Completed NCT00002093 Phase 3 Daunorubicin (liposomal);Bleomycin sulfate;Vincristine sulfate;Doxorubicin hydrochloride
41 Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. Completed NCT00002147 Phase 3 Doxorubicin hydrochloride (liposomal)
42 A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy Completed NCT02049905 Phase 3 Aldoxorubicin;Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
43 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Administered to Patients With High-Risk Sarcoma Receiving Intensive Chemotherapy (Adriamycin and Ifosfamide (AI)) Completed NCT00038311 Phase 3 PN-152,243)/PN-196,444
44 Double-Blind Randomized Evaluation of Clinical Benefits of DOXIL in Patients With AIDS-Related Kaposi's Sarcoma Treated With DOXIL or DaunoXome Completed NCT00002985 Phase 3 daunorubicin hydrochloride;pegylated liposomal doxorubicin hydrochloride
45 Open Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma Completed NCT00002319 Phase 3 Doxorubicin hydrochloride (liposomal)
46 Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma Completed NCT00002105 Phase 3 Doxorubicin hydrochloride (liposomal);Bleomycin sulfate;Vincristine sulfate
47 Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
48 A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma. Completed NCT01168791 Phase 3 doxorubicin in combination with palifosfamide-tris;doxorubicin in combination with placebo
49 A Randomized Phase III Trial Comparing Trabectedin (Yondelis®) to the Best Supportive Care in Patients With Advanced Soft Tissue Sarcoma Completed NCT02672527 Phase 3 Trabectedin;Dexamethasone
50 Phase III Prospective Randomized Trial of Pre-Operative Intensity Modulated Radiation Therapy (IMRT) Plus Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma Completed NCT00131898 Phase 3

Search NIH Clinical Center for Malignant Mesenchymoma

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Ifosfamide
Mitoxantrone
Mitoxantrone Hydrochloride
Thiotepa

Cochrane evidence based reviews: malignant mesenchymal tumor

Genetic Tests for Malignant Mesenchymoma

Anatomical Context for Malignant Mesenchymoma

MalaCards organs/tissues related to Malignant Mesenchymoma:

40
Bone, Lung, T Cells, Breast, Uterus, Brain, Liver

Publications for Malignant Mesenchymoma

Articles related to Malignant Mesenchymoma:

(show top 50) (show all 445)
# Title Authors PMID Year
1
Important prognostic factors in leiomyosarcoma survival: a National Cancer Database (NCDB) analysis. 61
31392646 2020
2
Uterine PEComa with aggressive behavior: A review with an additional case of spontaneous vaginal expulsion. 61
32527449 2020
3
Progress in determining response to treatment in gastrointestinal stromal tumor. 61
32191549 2020
4
[The role of interleukin-11 in osteosarcoma]. 61
32078699 2020
5
Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience. 61
31750944 2020
6
Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model. 61
31896528 2020
7
Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of BIRC3/YAP1 as Double Minutes Plus Trisomy 2: A Case Report. 61
31215292 2020
8
A case of hepatic leiomyosarcoma with osteosarcomatous differentiation (malignant mesenchymoma) in a dog. 61
32051664 2020
9
MDM2 dual-color in situ hybridization (DISH) aids the diagnosis of intimal sarcomas. 61
31442826 2019
10
Non-epithelial tumors of the larynx: case series of 12 years. 61
31256243 2019
11
Conjunctival Leiomyosarcoma, a Rare Neoplasm Always Originating at the Limbus? Report of a New Case and Review of 11 Published Cases. 61
31559244 2019
12
Cluster of Differentiation 10 Positive Stromal Sarcoma of Breast: A Diagnostic Challenge. 61
31523571 2019
13
Bilateral Anterior Uveitis in a Northern Saw-whet Owl (Aegolius acadicus) With a Metastatic Pectoral Malignant Mesenchymoma. 61
31251505 2019
14
A girl with a giant fibrolipoma in her thoracic cavity: a rare case report. 61
31060610 2019
15
Dermatofibrosarcoma protuberans: surgical management of a challenging mesenchymal tumor. 61
31138233 2019
16
Imaging findings of ovarian leiomyosarcoma with histopathologic correlations. 61
30898403 2019
17
Rare malignant glomus tumor of the stomach with liver metastases. 61
30766648 2019
18
Deep dermal and subcutaneous canine hemangiosarcoma in the perianal area: diagnosis of perianal mass in a dog. 61
30987633 2019
19
Scapula chondrosarcoma: A case report. 61
31027132 2019
20
Retroperitoneal Liposarcoma Masquerading as an Impending Rupture of Inflammatory Abdominal Aortic Aneurysm. 61
30496898 2019
21
Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study. 61
30932400 2019
22
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report. 61
30675302 2019
23
Recurrent intrathoracic dedifferentiated liposarcoma: A case report and literature review. 61
30847274 2019
24
Rare Breast Malignancy Subtypes: A Cytological, Histological, and Immunohistochemical Correlation. 61
31007516 2019
25
Lesser Sac Glomangiosarcoma With Simultaneous Liver And Lymph Nodes Metastases Mimicking Small Bowel Gastrointestinal Stromal Tumor; Immunohistochemistry And Empirical Chemotherapy. 61
31814776 2019
26
A Case of Undifferentiated Sarcoma in the Superior Vena Cava and Bilateral Cervical Veins. 61
30563958 2018
27
Laryngeal synovial sarcoma: Report of 2 cases. 61
30482506 2018
28
A giant primary hepatic low-grade malignant mesenchymal tumor of the liver in a teenager. 61
30652103 2018
29
Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution. 61
30007495 2018
30
Clinicopathological features, treatment and survival outcomes of synovial sarcoma. 61
30430100 2018
31
Low-grade endometrial stromal sarcoma presenting as multiple pulmonary nodules: A potential pitfall in fine needle aspiration and core biopsy specimens - A Cytological - Pathological Correlation. 61
30055523 2018
32
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups. 61
29781567 2018
33
Long period of relative quiescence in distal-type epithelioid sarcoma of the forearm with recurrence after surgery: A case report. 61
30200169 2018
34
Clinical and pathological characteristics of a series of patients with newly diagnosed primary renal liposarcoma: natural history and effect on survival. 61
29991665 2018
35
Metaplastic spindle cell carcinoma of the breast in a patient with neurofibromatosis type 1. 61
29139585 2018
36
Desmoplastic small round cell tumor of the middle ear: A case report. 61
29703011 2018
37
[A Case of Adult Undifferentiated Sarcoma of the Liver with Intraatrial Metastasis]. 61
29650847 2018
38
Primary pulmonary synovial sarcoma: A reappraisal. 61
29893303 2018
39
Primary Colonic Angiosarcoma Seen in a Patient on Calcium Channel Blocker: A Case Report with Summary Analysis of 32 Other Cases from the Literature. 61
29511155 2018
40
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study. 61
29211298 2018
41
Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase. 61
29399290 2018
42
Alveolar rhabdomyosarcoma in an adolescent male patient - case report and current perspectives. 61
30845308 2018
43
Benign osseous metaplasia of the breast: Case report. 61
29482081 2018
44
Hepatic epithelioid hemangioendothelioma: A great mimicker. 61
30366173 2018
45
A case of primary gastric undifferentiated high-grade pleomorphic sarcoma diagnosed with chief complaint of fever: a case report and literature review. 61
28276003 2017
46
A case of adult undifferentiated embryonal sarcoma of the liver successfully treated with right trisectionectomy: a case report. 61
28144858 2017
47
Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma. 61
29142603 2017
48
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. 61
29100276 2017
49
Primary malignant mesenchymoma of bladder: Case report and review of the literature. 61
28796040 2017
50
Conjunctival leiomyosarcoma: A case report and review of literature. 61
28573999 2017

Variations for Malignant Mesenchymoma

Expression for Malignant Mesenchymoma

Search GEO for disease gene expression data for Malignant Mesenchymoma.

Pathways for Malignant Mesenchymoma

Pathways related to Malignant Mesenchymoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.9 MYOG MYOD1 DES CD34

GO Terms for Malignant Mesenchymoma

Biological processes related to Malignant Mesenchymoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular response to estradiol stimulus GO:0071392 9.48 MYOG MYOD1
2 skeletal muscle fiber development GO:0048741 9.46 MYOG MYOD1
3 positive regulation of myoblast differentiation GO:0045663 9.43 MYOG MYOD1
4 muscle organ development GO:0007517 9.43 SMTN MYOG MYOD1
5 positive regulation of myoblast fusion GO:1901741 9.4 MYOG MYOD1
6 myoblast differentiation GO:0045445 9.37 MYOG MYOD1
7 myotube differentiation GO:0014902 9.32 MYOG MYOD1
8 positive regulation of skeletal muscle fiber development GO:0048743 9.16 MYOG MYOD1
9 muscle cell fate commitment GO:0042693 8.96 MYOG MYOD1
10 positive regulation of muscle cell differentiation GO:0051149 8.8 MYOG MYOD1 MDM2

Sources for Malignant Mesenchymoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....